Patients with SSc who have gastric dysmotility present with a more severe disease phenotype and are associated with an increased risk for adverse outcomes.

Use of GLP-1s or glucose-dependent insulinotropic polypeptide agonists before upper endoscopy significantly increased the risk for residual gastric volume, according to data published in JAMA Internal ...

A study in Gut shows that gastric cancer is shaped by complex interactions between environmental exposure, microbes, host, and tumor biology. The findings reveal distinct cancer routes and targets ...

Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to standard of care immunochemotherapy in patients with first ...

Gastric cancer remains the fifth leading cause of cancer-related deaths worldwide. Although its overall incidence has declined, early-onset cases—diagnosed before age 50—display unique biological and ...

Shares of Jazz Pharmaceuticals JAZZ rose nearly 21% on Monday after it announced positive top-line results from the late-stage HERIZON-GEA-01 study. This study evaluated different combination regimens ...

A vegan, allergy-friendly meal alternative demonstrated comparable performance to the standard egg-based meal for gastric emptying scintigraphy, with consistent agreement in retention times and ...

First overall survival (OS) results from Arm A1 of the Phase 2 EDGE-Gastric study will be presented on October 18 at the European Society for Medical Oncology (ESMO) 2025 Congress These data support ...

New guidelines establish standards for diagnosing and managing gastroparesis, or delayed stomach emptying. Gastroparesis has drawn renewed attention with the surge in use of GLP-1 receptor agonists ...

Gastroparesis affects thousands of people, often causing nausea, postprandial fullness, vomiting, discomfort, and major disruptions to quality of life. Bethesda, MD (Sept. 17, 2025) — The American ...